<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Posts on Aaron Lee</title>
    <link>//localhost:1313/posts/</link>
    <description>Recent content in Posts on Aaron Lee</description>
    <generator>Hugo</generator>
    <language>en-GB</language>
    <lastBuildDate>Fri, 07 Feb 2025 17:48:38 +0000</lastBuildDate>
    <atom:link href="//localhost:1313/posts/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>Warwick iGEM 2024: moving metal with bacteria</title>
      <link>//localhost:1313/posts/igem/</link>
      <pubDate>Fri, 07 Feb 2025 17:48:38 +0000</pubDate>
      <guid>//localhost:1313/posts/igem/</guid>
      <description>&lt;p&gt;&lt;img src=&#34;//localhost:1313/posts/igem/parisigemnight.webp&#34; alt=&#34;Photograph of the team all together. Me on the far right.&#34;&gt;&lt;/p&gt;&#xA;&lt;p&gt;From February to October 2024, I competed in the &lt;a href=&#34;https://competition.igem.org/&#34; target=&#34;_blank&#34;&gt;international&#xA;Genetically Engineered Machines (iGEM)&#xA;competition&lt;/a&gt;—where competitors&#xA;developed engineered biological solutions for a variety of problem&#xA;spaces.&lt;/p&gt;&#xA;&lt;p&gt;I was a member of the 2024 University of Warwick team,&#xA;&lt;a href=&#34;https://2024.igem.wiki/warwick&#34; target=&#34;_blank&#34;&gt;BEACON&lt;/a&gt;, working together to engineer&#xA;bacteria with the abilities to scavenge for rare earth metals, then to&#xA;transport them to a singular point for collection to be recycled. We&#xA;were one of 210 teams&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt; to be awarded a gold medal at the Paris&#xA;Jamboree.&lt;/p&gt;</description>
    </item>
    <item>
      <title>LinkedIn purgatory and this website</title>
      <link>//localhost:1313/posts/linkedin/</link>
      <pubDate>Thu, 06 Feb 2025 17:17:05 +0000</pubDate>
      <guid>//localhost:1313/posts/linkedin/</guid>
      <description>&lt;p&gt;TLDR: LinkedIn has randomly disabled my account, having prevented me&#xA;from logging in due to a broken login system, then demanded my&#xA;passport/driving licence to reinstate my account, before then blocking&#xA;me from even giving that to them anyway.&lt;/p&gt;&#xA;&lt;hr&gt;&#xA;&lt;p&gt;Greetings all, and welcome to the first post&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt; on this website—a website&#xA;born not of love, but of hate, vice, and spite.&lt;/p&gt;&#xA;&lt;p&gt;Which is not to say that I haven&amp;rsquo;t taken care in creating this&#xA;site. Quite the opposite, I intend to populate it with quality&#xA;writings.&lt;/p&gt;</description>
    </item>
    <item>
      <title>Attempting to cure my eczema by electrical shock</title>
      <link>//localhost:1313/posts/eczematens/</link>
      <pubDate>Wed, 05 Jun 2024 21:37:17 +0000</pubDate>
      <guid>//localhost:1313/posts/eczematens/</guid>
      <description>&lt;p&gt;For the past 10 years or so, I have been suffering from moderate&#xA;eczema. As anyone with eczema would know, this is incredibly&#xA;irritating to deal with, and practically impossible to treat.&lt;/p&gt;&#xA;&lt;p&gt;But we can try. So with the topical corticosteroids prescribed by my&#xA;doctor only serving to temporarily quell the condition, with a risk of&#xA;withdrawal syndrome, I elected to look for other solutions.&lt;/p&gt;&#xA;&lt;p&gt;Helge Bjørnå and Birger Kaada (1987) describe an experimental&#xA;treatment by transcutaneous electrical nerve stimulation (TENS). These&#xA;are available to consumers as a TENS unit, which is a little box with&#xA;dials that can control the strength and frequency of electrical pulses&#xA;sent to pads attached to your skin. This was intended to improve&#xA;circulation in the skin and thus promote healing and relief of&#xA;itching. After 2 years, they observed significant improvement in both,&#xA;though this was only tested in a singular patient.&lt;/p&gt;</description>
    </item>
  </channel>
</rss>
